Ophthalmic Epidemiology and Biostatistics

Understanding patterns in vision loss is fundamental to shaping effective interventions. Ophthalmic epidemiology and biostatistics provides the tools to analyze disease burden, risk factors, and population trends in ocular health. Large-scale studies such as the Blue Mountains Eye Study and the Beaver Dam Eye Study have informed screening guidelines, resource allocation, and public health policy. Statistical methods enable researchers to evaluate treatment efficacy, monitor adverse events, and assess the impact of interventions across demographics. The rise of big data, AI, and predictive modeling is expanding analytic capabilities in real time. As eye care becomes more data-driven, training in biostatistics and epidemiologic principles is essential for clinicians and researchers. Rigorous methodology ensures that evidence generated is valid, generalizable, and actionable—paving the way for more equitable and effective eye health strategies globally.